The efficacy of amrubicin on central nervous system metastases originating from small-cell lung cancer: a case series of eight patients
Conclusions The results of this study suggest that amrubicin is active in patients with CNS metastases originating from SCLC.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Drugs & Pharmacology | Investigational New Drugs | Lung Cancer | Small Cell Lung Cancer | Study